In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon Restructuring

This article was originally published in The Rose Sheet

Executive Summary

Direct seller will lay off more than 900 employees as part of its "ongoing process to take layers out of the organization," Avon reports in 8-K filed May 24. Move is part of company's multi-year restructuring effort. Initiative will result in charges of about $25 mil.-$30 mil. before taxes, and company notes it is likely to announce further exit and disposal costs related to restructuring initiatives. Earlier this month, Avon announced plans to cut 1,300 employees also in line with restructuring initiatives. Avon unveiled the multi-year restructuring plan aimed at restoring growth last fall, noting it will result in costs of $300 mil.-$500 mil. before taxes, a significant portion of which will be taken this year (1"The Rose Sheet" Nov. 21, 2005, p. 3)...

You may also be interested in...



Avon Restructuring Initiative Aimed At Restoring Growth

Avon will launch several new skin care and color cosmetics initiatives next year and significantly increase advertising investment in an effort to restore competitiveness and drive revenue growth, according to CEO Andrea Jung

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013959

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel